# FDA recall D-0482-2017

> **RemedyRepack Inc.** · Class II · drug recall initiated 2017-02-07.

## Product

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

## Reason for recall

Failed Dissolution Specifications

## Distribution

Product was distributed to  a sold customer in FL.

## Key facts

- **Recall number:** D-0482-2017
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-02-07
- **Report date:** 2017-03-01
- **Termination date:** 2017-05-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0482-2017

## Citation

> AI Analytics. FDA recall D-0482-2017. Retrieved 2026-06-01 from https://api.ai-analytics.org/recall/D-0482-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*